JP2009513689A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009513689A5 JP2009513689A5 JP2008538353A JP2008538353A JP2009513689A5 JP 2009513689 A5 JP2009513689 A5 JP 2009513689A5 JP 2008538353 A JP2008538353 A JP 2008538353A JP 2008538353 A JP2008538353 A JP 2008538353A JP 2009513689 A5 JP2009513689 A5 JP 2009513689A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- amino acid
- sdf
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05110206 | 2005-10-31 | ||
| US73414205P | 2005-11-07 | 2005-11-07 | |
| PCT/EP2006/067949 WO2007051785A2 (en) | 2005-10-31 | 2006-10-30 | Use of sdf-1 for the treatment and/or prevention of neurological diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009513689A JP2009513689A (ja) | 2009-04-02 |
| JP2009513689A5 true JP2009513689A5 (https=) | 2009-12-17 |
Family
ID=35967039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008538353A Pending JP2009513689A (ja) | 2005-10-31 | 2006-10-30 | 神経学的疾患の治療、及び／又は予防のためのｓｄｆ−１の使用 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20080253996A1 (https=) |
| EP (1) | EP1942940A2 (https=) |
| JP (1) | JP2009513689A (https=) |
| KR (1) | KR20080060226A (https=) |
| CN (1) | CN101300031A (https=) |
| AR (1) | AR058173A1 (https=) |
| AU (1) | AU2006310577B2 (https=) |
| BR (1) | BRPI0617823A2 (https=) |
| CA (1) | CA2617598A1 (https=) |
| EA (1) | EA015716B1 (https=) |
| NZ (1) | NZ565639A (https=) |
| UA (1) | UA96926C2 (https=) |
| WO (1) | WO2007051785A2 (https=) |
| ZA (1) | ZA200800981B (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7696309B2 (en) | 2006-10-23 | 2010-04-13 | The Brigham And Women's Hospital, Inc. | Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage |
| WO2011106234A1 (en) * | 2010-02-25 | 2011-09-01 | Provasculon, Inc. | Protease-resistant mutants of stromal cell derived factor-1 in the repair of tissue damage |
| US9249204B2 (en) * | 2011-06-01 | 2016-02-02 | Jyant Technologies, Inc. | Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof |
| JP6145089B2 (ja) * | 2011-06-07 | 2017-06-07 | メソブラスト インターナショナル エスエイアールエル | ストロマ細胞由来因子−１のプロテアーゼ耐性変異体を用いた、組織損傷を修復するための方法 |
| US11419916B2 (en) * | 2012-09-11 | 2022-08-23 | Energesis Pharmaceuticals, Inc. | Methods and compositions for inducing differentiation of human brown adipocyte progenitors |
| US9797910B2 (en) | 2013-06-19 | 2017-10-24 | Merck Sharp & Dohme Corp. | Assay for determining endogenous levels of analyte in vivo |
| EP3191991B1 (en) * | 2014-09-10 | 2021-01-13 | Koninklijke Philips N.V. | Image report annotation identification |
| ITUA20161364A1 (it) | 2016-03-04 | 2017-09-04 | Antonino Cattaneo | Inibitore di tnf alpha astrocitario per l’uso nel trattamento di malattie neurologiche. |
| US20180222957A1 (en) * | 2017-02-03 | 2018-08-09 | Vicapsys, Inc. | Modified cxcl12 polypeptides and uses thereof |
| CN107325187B (zh) * | 2017-07-19 | 2021-11-09 | 黄子为 | 一种具有cxcr4蛋白激动活性的多肽及其应用和药物组合物 |
| US11553871B2 (en) | 2019-06-04 | 2023-01-17 | Lab NINE, Inc. | System and apparatus for non-invasive measurement of transcranial electrical signals, and method of calibrating and/or using same for various applications |
| WO2023081458A1 (en) * | 2021-11-08 | 2023-05-11 | Rutgers, The State University Of New Jersey | Systems and methods for diagnosis and/or treating demyelinating neuropathy |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2145744T5 (es) | 1991-01-18 | 2008-02-01 | Amgen Inc. | Procedimientos para tratar las enfermedades inducidas por el factor de necrosis tumoral. |
| CA2117953C (en) * | 1993-10-14 | 2001-12-11 | Tasuku Honjo | Human stromal derived factor 1 alpha and 1 beta and dnas encoding the same |
| JP2002506830A (ja) * | 1998-03-13 | 2002-03-05 | ザ ユニバーシティ オブ ブリティッシュ コロンビア | 治療的ケモカイン受容体アンタゴニスト |
| CA2245224A1 (en) * | 1998-08-14 | 2000-02-14 | Jiang-Hong Giong | Chemokine receptor antagonists and chemotherapeutics |
| US7157418B1 (en) * | 1998-07-22 | 2007-01-02 | Osprey Pharmaceuticals, Ltd. | Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders |
| DE10027383A1 (de) * | 2000-06-02 | 2001-12-20 | Rhein Biotech Proz & Prod Gmbh | Nukleinsäure-Molekül umfassend eine für ein Chemokin, einen Neuropeptid-Präkursor oder mindestens ein Neuropeptid kodierende Nukleinsäuresequenz |
| US20040037811A1 (en) * | 2002-08-22 | 2004-02-26 | The Cleveland Clinic Foundation | Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy |
| EP1493438A1 (en) * | 2003-07-03 | 2005-01-05 | Bayer HealthCare AG | Vanilloid receptor (VR) inhibitors for treatment of Human Immunodeficiency Virus (HIV)-mediated pain states |
| WO2005042561A2 (en) * | 2003-10-31 | 2005-05-12 | Neuren Pharmaceuticals Limited | Neural regeneration peptides and methods of use |
-
2006
- 2006-10-30 JP JP2008538353A patent/JP2009513689A/ja active Pending
- 2006-10-30 UA UAA200802964A patent/UA96926C2/ru unknown
- 2006-10-30 EA EA200801244A patent/EA015716B1/ru not_active IP Right Cessation
- 2006-10-30 ZA ZA200800981A patent/ZA200800981B/xx unknown
- 2006-10-30 WO PCT/EP2006/067949 patent/WO2007051785A2/en not_active Ceased
- 2006-10-30 BR BRPI0617823-5A patent/BRPI0617823A2/pt not_active IP Right Cessation
- 2006-10-30 NZ NZ565639A patent/NZ565639A/en not_active IP Right Cessation
- 2006-10-30 EP EP06807673A patent/EP1942940A2/en not_active Ceased
- 2006-10-30 CA CA002617598A patent/CA2617598A1/en not_active Abandoned
- 2006-10-30 CN CNA2006800404916A patent/CN101300031A/zh active Pending
- 2006-10-30 US US12/067,224 patent/US20080253996A1/en not_active Abandoned
- 2006-10-30 AU AU2006310577A patent/AU2006310577B2/en not_active Ceased
- 2006-10-30 KR KR1020087007031A patent/KR20080060226A/ko not_active Ceased
- 2006-10-31 AR ARP060104776A patent/AR058173A1/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1425028B1 (en) | Use of il-18 inhibitors for the treatement or prevention of sepsis | |
| ES2690147T3 (es) | Apelina pegilada y usos de la misma | |
| CN103476933B (zh) | 白介素1受体的拮抗剂 | |
| JP2010518079A5 (https=) | ||
| US20120058083A1 (en) | Therapies for Chronic Inflammatory Demyelinating Polyneuropathy Using Interferon-Beta | |
| JP2009513689A5 (https=) | ||
| KR100520723B1 (ko) | 파골(破骨)세포 형성 억제제 | |
| JP2006513990A5 (https=) | ||
| JP2011078434A (ja) | 変異ニューブラスチンのポリマー結合体 | |
| CN101671390B (zh) | 人干扰素α衍生物及其聚乙二醇化修饰物的制备和用途 | |
| US9217018B2 (en) | HSP70 fusion protein conjugates and uses thereof | |
| CN101880326B (zh) | 干扰素‑β复合物 | |
| WO2006028497A2 (en) | Active recombinant human lysozyme | |
| CN111788217A (zh) | 白介素-15活性的拮抗剂肽 | |
| EP1799248B1 (en) | Use of il-17f for the treatment and/or prevention of neurologic diseases | |
| JP2001523727A (ja) | 造血幹細胞を可動化する方法 | |
| AU2002309887A1 (en) | Use of IL-18 inhibitors for the treatment or prevention of sepsis |